Search research articles
Contact Us
Filters
Showing results (21-30 of 327) with videos related to
Page
of 33
Sort By:
Ocular Immunology and Inflammation
|
July 13, 2017
Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series
Hande Celiker, Haluk Kazokoglu, Haner Direskeneli
Rheumatology (Oxford, England)
|
October 3, 2017
Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited
Gokhan Keser, Kenan Aksu, Haner Direskeneli
BMC Ophthalmology
|
October 7, 2018
Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents
Hande Celiker, Haluk Kazokoglu, Haner Direskeneli
Current Rheumatology Reports
|
March 31, 2026
Management of Severe Behçet's Disease
Kerem Abacar, Haner Direskeneli, Fatma Alibaz-Oner
The Journal of Allergy and Clinical Immunology
|
September 1, 2011
Regulation of TH17 and regulatory T cells in patients with Behçet disease
Haner Direskeneli, Hiroyuki Fujita, Cezmi A Akdis
Turkish Journal of Medical Sciences
|
February 13, 2021
Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspects
Hakan Emmungil, Ufuk İlgen, Rafi Haner Direskeneli
Current Opinion in Rheumatology
|
September 29, 2017
An update on the role of epigenetics in systemic vasculitis
Patrick Coit, Haner Direskeneli, Amr H Sawalha
American Journal of Ophthalmology
|
May 26, 2009
Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease
Sumru Onal, Haluk Kazokoglu, Haner Direskeneli, et al.
The Lancet. Rheumatology
|
January 24, 2025
Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy
Kerem Abacar, Tom Macleod, Haner Direskeneli, et al.
European Journal of Rheumatology
|
October 7, 2016
Recent advances in Takayasu's arteritis
Fatma Alibaz-Öner, Sibel Zehra Aydın, Haner Direskeneli
Page
of 33
Search research articles
Search
Showing results (21-30 of 327) with videos related to
Sort By:
Page
of 33
Ocular Immunology and Inflammation
|
July 13, 2017
Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series
Hande Celiker, Haluk Kazokoglu, Haner Direskeneli
Rheumatology (Oxford, England)
|
October 3, 2017
Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited
Gokhan Keser, Kenan Aksu, Haner Direskeneli
BMC Ophthalmology
|
October 7, 2018
Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents
Hande Celiker, Haluk Kazokoglu, Haner Direskeneli
Current Rheumatology Reports
|
March 31, 2026
Management of Severe Behçet's Disease
Kerem Abacar, Haner Direskeneli, Fatma Alibaz-Oner
The Journal of Allergy and Clinical Immunology
|
September 1, 2011
Regulation of TH17 and regulatory T cells in patients with Behçet disease
Haner Direskeneli, Hiroyuki Fujita, Cezmi A Akdis
Turkish Journal of Medical Sciences
|
February 13, 2021
Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspects
Hakan Emmungil, Ufuk İlgen, Rafi Haner Direskeneli
Current Opinion in Rheumatology
|
September 29, 2017
An update on the role of epigenetics in systemic vasculitis
Patrick Coit, Haner Direskeneli, Amr H Sawalha
American Journal of Ophthalmology
|
May 26, 2009
Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease
Sumru Onal, Haluk Kazokoglu, Haner Direskeneli, et al.
The Lancet. Rheumatology
|
January 24, 2025
Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy
Kerem Abacar, Tom Macleod, Haner Direskeneli, et al.
European Journal of Rheumatology
|
October 7, 2016
Recent advances in Takayasu's arteritis
Fatma Alibaz-Öner, Sibel Zehra Aydın, Haner Direskeneli
Page
of 33